HOOKIPA Pharma (HOOK) Revenue & Revenue Breakdown
HOOKIPA Pharma Revenue Highlights
Latest Revenue (Y)
$20.13M
Main Segment (Y)
Grant
Main Geography (Y)
Grant
HOOKIPA Pharma Revenue by Period
HOOKIPA Pharma Revenue by Year
Date | Revenue | Change |
---|---|---|
2023-12-31 | $20.13M | 41.27% |
2022-12-31 | $14.25M | -22.76% |
2021-12-31 | $18.45M | -5.80% |
2020-12-31 | $19.58M | 63.99% |
2019-12-31 | $11.94M | 56.53% |
2018-12-31 | $7.63M | 100.00% |
2017-12-31 | - | - |
HOOKIPA Pharma Revenue by Quarter
Date | Revenue | Change |
---|---|---|
2024-09-30 | - | -100.00% |
2024-06-30 | $1.29M | -96.48% |
2024-03-31 | $36.60M | 394.11% |
2023-12-31 | $7.41M | 7.86% |
2023-09-30 | $6.87M | 156.33% |
2023-06-30 | $2.68M | -15.65% |
2023-03-31 | $3.18M | -59.43% |
2022-12-31 | $7.83M | 251.03% |
2022-09-30 | $2.23M | -18.79% |
2022-06-30 | $2.75M | 90.03% |
2022-03-31 | $1.45M | -62.90% |
2021-12-31 | $3.90M | 0.54% |
2021-09-30 | $3.87M | -27.97% |
2021-06-30 | $5.38M | 1.45% |
2021-03-31 | $5.30M | 2.67% |
2020-12-31 | $5.16M | 27.80% |
2020-09-30 | $4.04M | -39.57% |
2020-06-30 | $6.68M | 80.87% |
2020-03-31 | $3.70M | 2.16% |
2019-12-31 | $3.62M | 77.53% |
2019-09-30 | $2.04M | -49.69% |
2019-06-30 | $4.05M | 81.25% |
2019-03-31 | $2.23M | -56.00% |
2018-12-31 | $5.08M | 167.37% |
2018-09-30 | $1.90M | 192.76% |
2018-06-30 | $649.00K | 100.00% |
2018-03-31 | - | - |
HOOKIPA Pharma Revenue Breakdown
HOOKIPA Pharma Revenue Breakdown by Product
Annual Revenue by Product
Product/Service | Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 19 |
---|---|---|---|---|---|
Grant | $300.00K | $600.00K | $800.00K | $700.00K | $800.00K |
Latest
HOOKIPA Pharma Revenue Breakdown by Country
Annual Revenue by Country
Country | Dec 22 | Dec 21 | Dec 20 | Dec 19 |
---|---|---|---|---|
Grant | $600.00K | $800.00K | $700.00K | $800.00K |
Latest
HOOKIPA Pharma Peer Comparison by Revenue
Ticker | Company | Last Year Revenue | Last Quarter Revenue |
---|---|---|---|
AMLX | Amylyx Pharmaceuticals | $380.79M | $416.00K |
HOOK | HOOKIPA Pharma | $20.13M | - |
MREO | Mereo BioPharma Group | $10.00M | - |
XFOR | X4 Pharmaceuticals | - | $560.00K |
PDSB | PDS Bio | - | - |
DAWN | Day One Biopharmaceuticals | - | $20.07M |
ABOS | Acumen Pharmaceuticals | - | - |
INZY | Inozyme Pharma | - | - |
TERN | Terns Pharmaceuticals | - | - |
ELDN | Eledon Pharmaceuticals | - | - |